| Vol. 5.41 – 23 November, 2020 |
| |
|
|
| RNA-sequencing analysis of peripheral blood mononuclear cells, single-cell bioinformatics analysis and immunohistochemistry of lung autopsy samples revealed that myelomonocytic cells and endothelial cells expressed high levels of PTX3 in patients with COVID-19. [Nature Immunology] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers examined expression of RIPK1 protein and mRNA in both human and mouse atherosclerotic lesions, and using loss-of-function approaches in vitro in macrophages and endothelial cells to measure inflammatory responses. They administered weekly injections of RIPK1 anti-sense oligonucleotides to Apoe-/- mice fed a cholesterol-rich diet for eight weeks. [Circulation] |
|
|
|
| Angiogenesis and β‐cell expansion in the pancreas were coupled by a distinct age‐dependent subset of endothelial cells (ECs). While this EC subpopulation supported pancreatic β cells, it declined during aging concomitant with increased expression of the gap junction protein Gja1. [EMBO Journal] |
|
|
|
| Human HCC cell lines were used to evaluate the colony formation, cell proliferation, migration, invasion, cell cycle and apoptosis after transfection of lentiviral short-hairpin RNAs targeting MYLK-AS1 or MYLK-AS1 vectors. [Journal of Experimental & Clinical Cancer Research] |
|
|
|
| Human adipose-derived stem cells were acquired from lipoaspiration and transfected with modRNAs. Transfection efficiency and expression kinetics of modRNAs in hADSCs were first evaluated in vitro. [Stem Cell Research & Therapy] |
|
|
|
| Investigators explored the therapeutic efficacy of human induced pluripotent stem cell (iPSC)‐derived endothelial cell and iPSC‐derived smooth muscle cell in peripheral artery disease model. [Stem Cells Translational Medicine] |
|
|
|
| The authors investigated the ability to activate endothelial primary cells by plasmatic extracellular vesicles (EVs) after both high and low particular matter (PM) exposure. Normal weight-high-PM EVs showed an increased endothelial activation, measured as CD105+/CD62e+ EVs ratio. [Scientific Reports] |
|
|
|
| Researchers introduced a microfluidic model of the solid tumor-vascular interface composed of a human umbilical vein endothelial cell (HUVEC)-lined, perfusable, bioengineered blood vessel and tumor spheroids embedded in an extracellular matrix. [Scientific Reports] |
|
|
|
| CXCR1 and CXCR2 were not detected on several clones of cord blood- endothelial colony-forming cell using different antibodies available, in contrast to well-known positive cells. [Stem Cell Reviews and Reports] |
|
|
|
| Investigators evaluated, in vitro, the potential paracrine effect of human adipose-derived stem cells to promote lymphangiogenesis in lymphatic endothelial cells isolated from rat diaphragmatic lymphatic vessels. [Regenerative Medicine] |
| |
|
|
|
| The authors summarize new lines of evidence that point to both platelet and endothelial dysfunction as essential components of COVID-19 pathology and describe the mechanisms that might account for the contribution of cardiovascular risk factors to the most severe outcomes in COVID-19. [Nature Reviews Cardiology] |
|
|
|
|
| Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the FDA has accepted for review the Biologics License Application for SB11, a proposed biosimilar referencing Lucentis®. Ranibizumab is an anti-VEGF therapy for retinal vascular disorders, which are a leading cause of blindness in the United States. [Samsung Bioepis Co., Ltd.] |
|
|
|
| Idorsia Ltd announced positive top-line results of the Japanese registration program investigating clazosentan in adult Japanese patients post-aneurysmal subarachnoid hemorrhage (aSAH). The program consisted of two double-blind, randomized, placebo-controlled studies assessing the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality events in adult Japanese patients following aSAH. [Idorsia Ltd] |
|
|
|
|
| October 4 – October 8, 2021 Singapore, Singapore |
|
|
|
|
|
| Radboudumcy – Nijmegen, Netherlands |
|
|
|
| Karolinska Institutet – Stockholm, Sweden |
|
|
|
| Stanford University – Stanford, California, United States |
|
|
|
| Novo Nordisk A/S – Copenhagen, Denmark |
|
|
|
| Universität Leipzig – Leipzig, Germany |
|
|
|
|